Venus Chemicals And Drugs Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
- Paid Up Capital ₹ 0.10 M
- Company Age 12 Year, 20 Days
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 26.74 Cr
- Satisfied Charges ₹ 4.10 Cr
- Revenue Growth -59.00%
- Profit Growth -70.33%
- Ebitda -45.13%
- Net Worth 12.41%
- Total Assets 34.35%
About Venus Chemicals And Drugs
Venus Chemicals And Drugs Private Limited (VCADPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 05 February 2013 and has a history of 12 years. Its registered office is in Kapra, Telangana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹26.74 Cr. The company has closed loans amounting to ₹4.10 Cr, as per Ministry of Corporate Affairs (MCA) records.
Indira Madderla, Sainath Madderla, and Madderla Shankar serve as directors at the Company.
Company Details
- Location
Kapra, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24100TG2013PTC085597
- Company No.
085597
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
05 Feb 2013
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Venus Chemicals And Drugs?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Indira Madderla  | Director | 05-Feb-2013 | Current |
| Sainath Madderla | Additional Director | 26-Feb-2018 | Current |
| Madderla Shankar | Director | 05-Feb-2013 | Current |
Financial Performance of Venus Chemicals And Drugs.
Venus Chemicals And Drugs Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 59% decrease. The company also saw a substantial fall in profitability, with a 70.33% decrease in profit. The company's net worth Soared by an impressive increase of 12.41%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Venus Chemicals And Drugs?
In 2023, Venus Chemicals And Drugs had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹26.74 Cr
₹4.10 Cr
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 26.74 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 28 Jul 2023 | Hdfc Bank Limited | ₹26.74 Cr | Open |
| 11 Nov 2021 | Others | ₹3.00 Cr | Satisfied |
| 04 Feb 2015 | Indian Overseas Bank | ₹1.10 Cr | Satisfied |
How Many Employees Work at Venus Chemicals And Drugs?
Venus Chemicals And Drugs has a workforce of 20 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Venus Chemicals And Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Venus Chemicals And Drugs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
